NovaBridge Biosciences (NBP)

NovaBridge Biosciences (NBP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $158M; returns 1 day +3.0%, 1 week +8.7%.

NovaBridge Biosciences (Nasdaq: NBP) is a global biotechnology platform company committed to accelerating access to innovative medicines. Formerly known as I-Mab, the company rebranded in October 2025 to reflect its strategic transformation. NovaBridge focuses on business development and translational clinical development to identify and advance pharmaceutical assets.

Groups NBP belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Bispecific Antibodies
• Immunotherapy
• Clinical Stage
• Antibody Therapeutics
• Biopharmaceutical
• Healthcare
• Ophthalmology
• PD-L1

NBP financial model: income statement, cash flow and balance sheet